Lyka Labs Revises Q1 FY27 Results Due to Typo

Lyka Labs Ltd has submitted a revised press release for its unaudited financial results for the quarter ended June 30, 2026. The revision corrects typographical errors in specific financial figures from the original filing on August 10, 2026. Key unaudited figures for Q1 FY27 include a standalone net total income increase of 42.67% to ₹4272.79 Lacs and a consolidated net total income increase of 26.95% to ₹4272.79 Lacs. Standalone net profit surged by 159.06% to ₹210.03 Lacs, while consolidated net profit rose by 105.44% to ₹204.66 Lacs. The company attributes revenue growth to strong performance in domestic and export markets, particularly in branded formulations and veterinary products. Standalone EBITDA margin decreased slightly to 11.84% from 14.16% year-on-year, and consolidated EBITDA margin fell to 11.74% from 13.07%. The company has requested the revised press release be taken on record and updated on its website.